Navigation Links
FutureFuel Corp. Declares Dividend
Date:5/21/2010

ST. LOUIS, May 21 /PRNewswire-FirstCall/ -- On May 21, 2010, FutureFuel Corp. (OTC Bulletin Board: FTFL) filed a Form 8K with the Securities and Exchange Commission declaring a special cash dividend of $0.20 per share.

The board of directors of FutureFuel Corp. (the "Company") has declared a special cash dividend of U.S. $0.20 per share on the Company's common stock, with a record date of June 8, 2010.  For purposes of the record date, those holders of the Company's warrants or options who properly exercise their warrants or options on or before June 8, 2010 will be considered holders of record on such date, whether or not new stock certificates have been issued to such holders by that date.

The dividend is payable June 30, 2010.

FutureFuel Corp. was created in 2005 as a special purpose acquisition vehicle to acquire companies and make a notable impact in the biofuel and fuel industries.  In October 2006, the Company purchased FutureFuel Chemical Company (formerly named "Eastman SE, Inc."), the owner and operator of a chemical and biodiesel manufacturing facility located near Batesville, Arkansas.  Since then, the Company has worked to become a leader in the U.S. biofuel industry, while maintaining the Batesville facility's status as a world-class specialty chemical manufacturer.


'/>"/>
SOURCE FutureFuel Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
3. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
4. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
5. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
6. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
7. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
8. Helix BioPharma Corp. announces fiscal 2007 results
9. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
10. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
11. Helix BioPharma Corp. announces management changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015 Research and Markets ( ... "Israel Biomedical Sensors Market - Growth, Trends & Forecasts ... The Israel Biomedical Sensors market is estimated at $0.19 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
(Date:8/31/2015)... 31, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... and developing innovative therapies primarily in the areas ... 30-day review period following the filing of the ... with the U.S. Food and Drug Administration (FDA) ... Logo -  http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:8/31/2015)... Aug. 31, 2015 LabStyle Innovations Corp. ... Solution, today announced it recently closed a round ... be used to support the global rollout and ... mobile, cloud-based, diabetes management solution that includes novel ... blood glucose monitoring device, and for working capital ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... There’s a ... Minerva is the first commercially available new FDA approved system in the last ... rate of 92%, the high Amenorrhea (zero bleeding) rate of 66%, the high Patient ...
Breaking Biology Technology:Israel Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 4U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3
... Ventaira Pharmaceuticals,announced today that Battelle, a science ... assist Ventaira in closing its,operations. Financial terms of ... be working with Battelle to transition our assets. ... explore employment,opportunities for our employees," said Leslie Williams, ...
... Researchers Advise Agendia, AMSTERDAM, October 29 ... the,rapidly evolving field of cancer molecular diagnostics ... Scientific Advisory Board. The newly,established Clinical and ... with research and clinical expertise.,The advisors review ...
... IDM Pharma, Inc.,(Nasdaq: IDMI ), a biotechnology ... today that Timothy P. Walbert,president and chief executive officer, ... in San Diego on Thursday, November 1, 2007,at 2 ... A webcast of the presentation will be available ...
Cached Biology Technology:Ventaira Pharmaceuticals Announces Acquisition of Assets by Battelle 2Agendia BV Appoints Clinical and Scientific Advisory Board 2IDM Pharma to Present at BIOCOM Investor Conference 2IDM Pharma to Present at BIOCOM Investor Conference 3
(Date:8/25/2015)... SALT LAKE CITY and BELLEVUE, ... a global leader in advanced robotic systems, announced today ... first-of-its-kind robotic unmanned ground vehicle (UGV), at the National ... Lake City.  The Guardian S is ... is the culmination of years of research and in-field ...
(Date:8/20/2015)... Aug. 20, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market and ... joined The Smart Card Alliance and the EMV Migration ... and the Smart Card Alliance Latin America (SCALA) Chapter ... peers and thought leaders promoting adoption of smart card ...
(Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2
... used to monitor water quality has been called into question by ... bacteria that might not indicate an environmental hazard. Fecal ... E. coli bacteria in the water because E. coli ... of humans and other warm-blooded animals, and quickly die outside its ...
... RIVERSIDE, Calif. Juicy. Extremely Sweet. Visually ... are the fine qualities that mark ,KinnowLS, the latest citrus ... Large-sized for a mandarin, the fruit has an orange ... The 10-11 segments in each fruit are fleshy and deep ...
... in a person, but in an infectious disease, it is ... host for decades before bursting forth into infection. TB,s stealthy ... seriously hampering efforts to control it. The World Health Organization ... infected. Now, a study led by Stanford scientists has ...
Cached Biology News:Study provides new way to classify E. coli bacteria and test for fecal contamination 2Study provides new way to classify E. coli bacteria and test for fecal contamination 3New citrus variety released by UC Riverside is very sweet, juicy and low-seeded 2New citrus variety released by UC Riverside is very sweet, juicy and low-seeded 3Tuberculosis strain spread by the fur trade reveals stealthy approach of epidemics 2Tuberculosis strain spread by the fur trade reveals stealthy approach of epidemics 3Tuberculosis strain spread by the fur trade reveals stealthy approach of epidemics 4
...
Verotoxin IIbeta (457)...
Features , Designed to assist users in applying domed caps to tube strips and plates , Minimises the pressure required to seal the caps effectively , Enables multiple tubes to be sealed simultaneousl...
Request Info...
Biology Products: